• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Heart Monitoring Smartwatch

iBeat Closes Additional $5.5M to Bring Wearable Heart Monitoring Smartwatch to Market

by Fred Pennic 05/02/2018 Leave a Comment

iBeat Extends Seed Round to $4.5M for Wearable Heart Monitoring Smartwatch

iBeat, makers of the heart monitoring smartwatch wearable that perpetually monitors and detects cardiac arrest, heart attack, and atrial fibrillation has closed another $5.5 million in seed funding, bringing to the total funding round to $10 million. The second tranche of funding includes new investors Kairos, 8VC, City Light Capital, Plug and Play Ventures, ChinaRock Capital Management, as well as angel investors Tony Robbins, Josh Kazam, Shlomo Ben-Haim, Dr. Fred St. Goar, and Dr. Uma
Read More

Dr. Oz Invests in iBeat to Launch Heart Monitoring Smartwatch on Indiegogo

by HITC Staff 09/29/2016 Leave a Comment

Mehmet Oz, famously known as Dr. Oz, has invested and partnered with digital health startup iBeat to launch a new heart monitoring smartwatch that empowers people to live longer lives on Indiegogo. The partnership with Dr. Oz kicks off with pre-orders for its iBeat Life Monitor – a watch that continuously monitors one’s heart for life threatening emergencies and notifies loved ones and emergency responders in such an event.As part of the investment partnership with iBeat, Dr. Oz, a world
Read More

iBeat Raises $1.5M To Commercialize Its Heart Monitoring Smartwatch

by Fred Pennic 08/02/2016 Leave a Comment

iBeat Extends Seed Round to $4.5M for Wearable Heart Monitoring Smartwatch

iBeat, makers of the heart monitoring smartwatch wearable that perpetually monitors and detects cardiac arrest, heart attack, and atrial fibrillation has raised $1.5M in seed funding. The oversubscribed seed round was led by Maveron, Subtraction Capital, and Correlation Ventures. Other investors include super-angels Ali and Hadi Partovi, NFL offensive tackle Russell Okung, KKR founding partner Henry Kravis, Band of Angels, and award-winning industrial design firm Ammunition Group. The digital
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |